News & Publications

The standard (“conventional”) way to give radiation for Merkel cell carcinoma (MCC) involves about 25 treatments given over a 5-week period. Because MCC patients are often older and may live quite far from a radiation therapy (RT) facility, a conventional course can be difficult to accomplish. F...

Several faculty, trainees and researchers representing UW Dermatology presented their research at the SID Annual Meeting in Portland, Oregon from May 18-21, 2022. Each year, the Society for Investigative Dermatology (SID)’s Annual Meeting invites a diverse group of researchers and clinicians, as w...

This study looked at 77 MCC patients who were diagnosed and treated in Europe. Thirty of the 77 patients were immune suppressed because of medications they take to prevent rejection of a transplanted organ (often a kidney). As has been found in some prior studies, a higher fraction of the immune sup...

The UW Division of Dermatology hosted the 2nd International Symposium on Merkel Cell Carcinoma in Seattle, WA, from April 25-26, 2022. The two-day hybrid (in-person and virtual) event held at the Graduate Hotel brought together over 140 thought leaders, active investigators, faculty and trainees in ...

The UW Division of Dermatology hosted the 2nd International Symposium on Merkel Cell Carcinoma in Seattle, Wash, from April 25-26, 2022. The two-day hybrid (in-person and virtual) event held at the Graduate Hotel brought together over 140 thought leaders, active investigators, faculty and trainee...

The annual update of the National Comprehensive Cancer Network guidelines for MCC has just been posted, with inclusion of ‘Evidence blocks’ that indicate effectiveness, cost, and side effects of various treatments.

The 16th Annual MCC Multi-center Interest Group (MMIG) Meeting took place on March 25, 2022 at the American Academy of Dermatology Annual Meeting in Boston, MA. Here we summarize talks given by Lisa Zaba, MD, PhD, Lindsay Gunnell, MD, Sophia Shalhout, PhD, Mackenzie Martin, BA, Anna Szumera-Cieckiew...

Congratulations to several members of the Nghiem Lab Research Team whose recent proposal was selected to receive over $1.2 million in award funding through The Mark Foundation to support their innovative Merkel cell carcinoma (MCC) research. The research team includes Peter Goff, MD, PhD, Senior...

Congratulations to UW Dermatology’s Nghiem Lab Research Team, and partners from around the world, who have recently been awarded a $4 million grant from Innovation Fund Denmark (IFD) to develop and clinically test the ImmPACT cell product in Merkel cell carcinoma. The project will explore the po...

This is a study of over 444,000 persons who receive immune suppression medications to prevent the rejection of a transplanted kidney, heart, or other organ. The authors found an inceased risk of multiple cancers that are caused by sunlight and or viruses. The chance of developing Merkel cell carcino...